Chemoinformaics analysis of Chrysoobtusin-1-O-Beta-D-Glucopyranoside
| Molecular Weight | 520.487 | nRot | 7 |
| Heavy Atom Molecular Weight | 492.263 | nRig | 24 |
| Exact Molecular Weight | 520.158 | nRing | 4 |
| Solubility: LogS | -3.354 | nHRing | 1 |
| Solubility: LogP | 1.296 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 65 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 12 |
| nHA | 12 | APOL | 70.0442 |
| nHD | 4 | BPOL | 40.2418 |
| QED | 0.329 |
| Synth | 4.031 |
| Natural Product Likeliness | 1.477 |
| NR-PPAR-gamma | 0.042 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.352 |
| Pgp-sub | 0.942 |
| HIA | 0.458 |
| CACO-2 | -5.629 |
| MDCK | 0.0000303 |
| BBB | 0.166 |
| PPB | 0.654626 |
| VDSS | 0.566 |
| FU | 0.222287 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.926 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.843 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.319 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.183 |
| CYP3a4-inh | 0.05 |
| CYP3a4-sub | 0.415 |
| CL | 5.208 |
| T12 | 0.173 |
| hERG | 0.051 |
| Ames | 0.668 |
| ROA | 0.292 |
| SkinSen | 0.012 |
| Carcinogencity | 0.046 |
| EI | 0.01 |
| Respiratory | 0.052 |
| NR-Aromatase | 0.596 |
| Antiviral | Yes |
| Prediction | 0.949409 |